IP Group is a London-based publicly listed investment firm focused on commercializing intellectual property from UK universities and research institutions. It invests from seed through growth and has built one of the largest university-linked venture portfolios in the UK. Its model is centered on translating academic research into investable businesses.

The firm invests across life sciences, medtech, materials, AI, and deep tech, and its portfolio includes multiple companies emerging from leading UK research institutions. Its relevance to neurotech comes from this university commercialization pipeline, especially in ecosystems such as Oxford, Cambridge, Bristol, and Imperial. IP Group is particularly important where a company’s core asset is defensible university-derived IP.

Its focus is overwhelmingly the United Kingdom. For neurotech, it is a highly relevant investor for academic spinouts and research-driven startups emerging from major UK neuroscience and engineering centers. It is one of the clearest institutional bridges from British lab science to venture-backed company formation.